Regeneron Pharmaceuticals Price to Free Cash Flow Ratio 2010-2024 | REGN
- Regeneron Pharmaceuticals average price to free cash flow ratio for 2023 was 22.84, a 75.83% increase from 2022.
- Regeneron Pharmaceuticals average price to free cash flow ratio for 2022 was 12.99, a 40.06% increase from 2021.
- Regeneron Pharmaceuticals average price to free cash flow ratio for 2021 was 21.67, a 33.79% decline from 2020.
Price to free cash flow ratio can be defined as